SUMMARY
INTRODUCTION
Lung cancer is a major public health problem worldwide. About 158,040 Americans and 610,200 Chinese died from lung cancer in 2015, with 27% and 20% of all cancer deaths, respectively [1, 2] . Lung cancer morbidity and mortality in Xuanwei has been among the highest in China for both males and females since the 1970s. The latest epidemiological studies showed lung cancer mortality in Xuanwei accounted for 63.03% of all deaths from cancers [3] . It is well known lung cancer is closely related to cigarette smoking [4] . Xuanwei female patients barely a report history of tobacco smoking, and have similar rates of lung cancer comparable to those of men (male-to-female ratio: 1.09:1 in Xuanwei, 2.07:1 in China, and 1.80:1 in the United States) [5] . Adenocarcinoma was the major histological type in Xuanwei patients, even though almost all men were smokers [6] , and the incidence peaks showed a more apparent trend of younger patients (41 -50 years), which is more than 10 years younger than the peak incidence of lung cancer in other areas of China [7] . Especially, burning smoky coal was strongly associated with the area's lung cancer risk [8] . Lung cancer in Xuanwei has distinctive characteristics, thus it is also referred to as Xuanwei lung cancer (LCXW). Xuanwei, located in southwestern province of Yunnan, China, is a coal-rich county and residents have traditionally burned "smoky coal" in unvented fire pits or stoves for home cooking and heating until the 1970s. Xuanwei smoky coal has relatively high aromatic and low sulfur content, and, as its name implies, smokes heavily on combustion [9] . Burning smoky coal in poor indoor ventilation condition generated high levels of particulate matter (up to 24.4 mg/m 3 ), extractable organic matter (up to 17.6 mg/m 3 ), and carcinogenic policyclic aromatic hydrocarbons (PAHs, up to 58.33 mg/ m 3 ) [10, 11] , leading to a 7.7-fold increased risk of the area's lung cancer and the risks were similar between women and men [12] . There is a positive association between time spent indoors at home and risk of lung cancer for females [13] . A long-term reduction in lung cancer incidence was noted after chimneys or portable stoves were installed in the 1990s [14] , supporting the association between smoky coal use and lung cancer. The overall lung cancer morbidity and mortality in this region, however, has been increasing [6, 15] . The pathogenesis by which smoky coal use leads to lung cancer risk remains poorly understood. Therefore, there is a huge need to identify promising genes which play a role in the incidence and development of LCXW. mRNA microarray analysis can examine patterns of expression of large numbers of genes simultaneously [16] .
This high-throughput technique can distinguish which genes are active and which are inactive in cancerous cells compared to their nearby normal cells and, therefore, can effectively screen cancer-related genes [17] . Identifying functional mRNA involved in the LCXW is still lacking. Here, we tried to screen out a potential cancer-related gene which may become a promising biomarker of LCXW through mRNA expression profiles.
MATERIALS AND METHODS

Patients and tissue samples
The study was approved by the Medical Ethics Committee of Kunming Medical University. All patients voluntarily joined this study and each provided an informed consent form. Seventy-three patients diagnosed with non-small cell lung cancers (NSCLCs) at the first affiliated hospital of Kunming Medical University were enlisted. The 29 paired samples collected at first were tested by microarrays and the remaining 44 paired samples were used to verify analysis. The patients enrolled met the following criteria: (1) the patients resided in Xuanwei city and never stayed in other regions; (2) the patients had not received radiotherapy or chemotherapy; (3) tumor and adjacent normal lung tissues (> 5 cm away from carcinoma tissues) were obtained. The tissue samples were collected at the time of surgery and then quickly frozen in liquid nitrogen until further use. Tumor histology was estimated by at least 2 pathologists. The tumor samples contained a tumor cellularity greater than 80% and the matched control samples had no cancer cells.
Gene expression microarray
The Agilent OligoMicroarray Kit 8×60K (Agilent Technologies, Santa Clara, CA, USA) was carried out on the 29 paired samples according to the Agilent One-Color Microarray-based Gene Expression Analysis Protocol (Agilent Technologies). Data preprocessing and differential expression analysis were carried out using Gene Spring Software GX 12.6 (Agilent Technologies, Santa Clara, California, USA). Paired sample t-test was used to calculate the differentially expressed genes between tumor and paired adjacent tissues. Fold-change ≥ 2 and p-value ≤ 0.05 was considered as differentially expressed genes.
Gene ontology (GO) and pathway enrichment analysis of differentially expressed genes The GO enrichment was analyzed via the online software Molecule Annotation System (MAS) (http:// bioinfo. capitalbio.com/mas3/) to promote the interpretation of biological roles of DEGs. The online software of KOBAS 2.0 was used for annotation and identification of enriched pathways of DEGs. The p-values ≤ 0.05 were chosen as significantly enriched.
RNA isolation and quantitative real-time PCR (qRT-PCR)
RNA was extracted from 44 paired LCXW samples using the AllPrep DNA/RNA Mini Kit (Qiagen, Germany), and cDNA was generated using PrimeScript Reverse Transcriptase (Takara Bio, Japan). qPCR was performed using the SYBR Premix DimerErase (Takara Bio, Japan) and the Applied Biosystems 7300 RealTime PCR System (Applied Biosystems, USA) was used for the analysis. The real-time PCR utilized the following primers: 5′-GCGGCAGCTGATTGTTAA GGA-3′ (forward) and 5′-GAGTCACTAGGGCCACC ATGAGA-3′ (reverse) for ANXA3, and 5′-CGCTGAG TACGTCGTGGAGTC-3′ (forward) and 5′-GCTGATC TTGAGGCTGTTGTC-3′ (reverse) for GAPDH. PCR was performed under the following conditions: 95°C for 3 minutes, 94°C for 15 seconds, 60°C for 30 seconds and 72°C for 30 seconds. Relative expression of ANXA3 mRNA level was calculated by the comparative CT method.
Western blotting
The cell lysate was prepared from 21 LCXW tumor and adjacent to tumor tissues using RIPA lysis buffer (Solarbio, China) containing protease inhibitor (Millipore, USA). The protein concentration was measured using a BCA protein assay (Solarbio, China). Approximately 100 μg protein samples were isolated in 10% acrylamide gel and transferred to PVDF membranes. The membranes were blocked for 2 hours at room temperature with 5% non-fat milk. Membranes then were incubated with rabbit anti-annexin A3 at 1:200 dilution (Abcam, USA) for overnight at 4°C. Mouse anti-β-actin (Abcam, USA) was used to normalize the amount of sample loaded. Next, the nonspecific binding of primary antibody was washed out and secondary antibody (goat-anti-rabbit HRP and goat-anti-mouse HRP) was added and incubated for 1 hour at room temperature. Later the signals are visualized with a chemiluminescent substrate reagent kit (Thermo Fisher Scientific, USA). The band intensity was measured by Image J software.
Statistical analysis
All quantitative data were presented as mean ± SD. Paired-sample t-test was applied to compare mRNA expression level between tumor tissue and matched adjacent non-tumor tissue. Wilcoxon rank sum test was used for comparisons of protein level in two independent groups. Correlations between ANXA3 expression and clinical features were conducted using Fisher's test. Statistical analysis was performed by using the Statistical Package for Social Sciences (SPSS) software (version 16.0). Statistical significance was accepted at p < 0.05.
RESULTS
Gene expression profiles of Xuanwei patients
The mean age of 29 LCXW patients was 49.2 ± 7.8 years, including 16 males and 13 females. According to the TNM staging, there were 11 patients in Stage I, 11 patients in Stage II, and 7 patients in Stage III. After normalization and data filtering, we found 2,424 distinct differentially expressed genes (DEGs) (fold change ≥ 2.0 and p-value ≤ 0.05) with 1,636 with up-regulated and 788 down-regulated genes. Cluster analysis of these DEGs indicated a distinct separation between the LCXW tumor and adjacent to tumor tissues (Figure 1 ).
GO and Pathway analysis of the DEGs
DNA bending complex (GO: 1990104), nucleosome (GO: 0000786), DNA packaging complex (GO: 0044 815), and protein-DNA complex (GO: 0032993) were significantly enriched in the category of GO cellular component. Nucleosome organization (GO: 0034728), chromatin assembly or disassembly (GO: 0006333), DNA conformation change (GO: 0071103), protein-DNA complex assembly (GO: 0065004), DNA packaging (GO: 0006323), nucleosome assembly (GO: 0006 334), and chromatin assembly (GO: 0031497) were significantly enriched in the category of GO biological process. While for the category of GO molecular function, only protein heterodimerization activity (GO: 0046 982) was significantly enriched (Figure 2 ). Pathway analysis showed these DEGs were involved in a wide range of pathways and biological function damage in LCXW patients, including cell cycle, DNA methylation, DNA damage, signal transduction pathways, etc. (Figure 3) .
PAHs exposure related DNA repair genes
Smoky coal emission generated high concentrations of polycyclic aromatic hydrocarbons (PAHs) that are important carcinogens [18] . PAHs react with DNA to form covalently bound DNA adducts and cause DNA repair processes to eliminate these alterations so that mutation does not occur [19] . We also identified 40 previously reported DNA repair genes (including RAD51AP1, TDP1, MCM8, PRKDC, DNA2, EXO1, CHEK2, AHNAK2, POLQ, RECQL4, BRCA1, etc.), which were consistent with previous research (Table 1 ) [20] . Interestingly, these genes were all up-regulated.
Down-regulated ANXA3 was identified by microarrays
We first screened consistent DEGs from different pathological stages, and a total of 462 genes were identified. Of these genes, 158 were up-regulated while the other 304 genes were down-regulated (Figure 4) . 462 DEGs which were detected among all samples were enrolled in analysis to further refine candidate genes. This resulted in 32 up-regulated and 80 down-regulated candidate genes ( Table 2) . Among these candidate genes, ANXA3 was frequently down-regulated in stage I, II, and III pa- tients (26/29, 89.7%). GO analysis indicated the coding gene ANXA3 was involved in the regulation of a variety of biological responses and is known to be secreted to extracellular space (Table 3) . Review of the literature on ANXA3 found its expression in lung adenocarcinoma occurring in other geographic areas was significantly up-regulated instead of down-regulated [21] . We focused on ANXA3 due to the differential expression patterns from LCXW and the characteristic of secreted proteins to serve as potential biomarkers.
The down-regulated of ANXA3 was associated with LCXW To identify ANXA3 critical to LCXW carcinogenesis, we expanded the observations in additional 44 pairs of tissues (tumor tissue and matched adjacent non-tumor tissue) by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Results revealed that ANXA3 was down-regulated in 35/44 (79.5%) of LCXW patients, and there were statistical differences in comparison to control group (9/44, 20.5%) (p < 0.01, Figure 5 ). Next, we further examined the protein levels of ANXA3 in 21 matched primary LCXW and non-tumor lung tissues from above 44 Xuanwei patients. As expected, only five LCXW cases (23.8%) were higher than that in normal tissues and the others (16/21, 76.2%) were all lower than in normal tissues. It showed that ANXA3 expression was suppressed in cancer tissues, and the difference remained statistically significant (p < 0.01; Figure 6 ).
The down-regulated of ANXA3 was associated with clinical pathological stage
According to the relative ANXA3 expression in tumor tissues, the 44 LCXW patients were divided into two groups including high expression of ANXA3 (n = 9) and low expression of ANXA3 (n = 35). From our results, we found no association of ANXA3 expression between age, gender, smoking status, lymph node metastasis and tumor size. In 44 cases, the tumor stage of 11 cases was advanced, 3 of which were stage IV. With the increase of the clinical stage, there was significant down-regula- tion in the cases for the expression of ANXA3 (p < 0.05). Combined with all these above results, it suggested that down-regulated ANXA3 significantly correlated with clinical pathological stage of LCXW (Table  4) .
DISCUSSION
In this study, we utilized the epidemiology profile of LCXW to explore the abnormalities in mRNAs that are critical to smoky coal-induced lung cancer. Our microarray analysis suggested that the LCXW patients harbored more DEGs, and these DEGs were involved in a wide range of pathway and biological function damage including PAHs exposure leading to up-regulation of DNA repair genes. In expanded validation experiments, we showed that ANXA3 was down-regulated in 35/44 (79.5%) of the LCXW patients and down-regulated for protein in 16/21 (76.2%) of the LCXW patients, suggesting that ANXA3 could be a LCXW related gene. We further evaluated the relationship between ANXA3 and clinical features and found that the down-regulated ANXA3 correlated to clinical pathological stage, implying the potential of ANXA3 as a possible diagnostic biomarker for LCXW. The focus of ANXA3 research has been centered on its expression in different types of cancer. An elevated expression of ANXA3 was detected in patients with colorectal cancer [22] , breast cancer [23] , gastric cancer [24] , hepatocellular carcinoma [25] , and so on. However, decreased ANXA3 expression was also found in prostate cancer [26] and in papillary thyroid cancer [27] . The above research results indicated that dysregulation of ANXA3 has a dual role in tumorigenesis. Here, our studies identified ANXA3 was down-regulated in tumor tissues and provided new evidence of ANXA3 acting as a cancer related gene in LCXW which may link to cancer initiation and progression. In relation to our report, Liu et al. showed ANXA3 expression in lung adenocarcinoma tissue was significantly up-regulated, and the over-expressed ANXA3 was an independent prognostic factor of recurrence in advanced clinical stage and lymphatic metastasis [21] . Our studies, however, were different from the previous study and this phenomenon has also been observed in previous studies. Wang et al. had shown CASP3 gene exhibits lower expression levels in smoky coal users compared with non-smoky coal users [28] . Wei et al. also found Xuanwei patients had many more dysregulated lncRNAs than patients from control regions where smoky coal was not used [29] . Yu et al. revealed LCXW harbored more genetic mutations and most genes in Xuanwei NSCLCs differed from those in other geographic areas [20] . These molecular observations showed that exposure to smoky coal emission caused a strong genotoxic effect thus exerting distinct characteristics at the molecular level. Notably, Xuanwei population also provided an example of the epidemiological association between genetic predisposition and lung cancer risk. People with a family history of lung cancer were found to be 1.60 times more likely to develop lung cancer than those with no family history; the parents and relatives of lung cancer probands were 2.66 and 2.64 times more likely to suffer from lung cancer than controls [30] . Individuals with the GSTM1-null genotype were more likely to have lung cancer than individuals with a GSTM1-positive genotype: the overall risk for lung cancer increased 1.7-fold per 100 tons of lifetime coal use (95% CI = 1.3 -2.4) [31] . Overall, these results demonstrated the pathogenesis of LCXW might be distinguished from that of lung cancers occurring in other geographic areas. Thus, we think that a plausible explanation for differential expression pattern of the ANXA3 in LCXW was the result of unique environment and certain susceptible population.
In the current study, the clinicopathological analysis confirmed that down-regulated ANXA3 were significantly (p < 0.05) associated with clinical stage and indicated a potential role of ANXA3 in promoting tumor development in LCXW. The data suggests that ANXA3 down-regulation might play an important role in the tumorigenesis, development, and progression of LCXW, and it may serve as a promising diagnostic marker in LCXW patients. There are some limitations to our study. The main limitation was the number of subjects. The scarcity of specimens led to collecting difficulties.
CONCLUSION
Despite this limitation, our report represents that the ANXA3 was down-regulated in tumor tissues compared to matched normal-tissues.
